The First Newsletter Dedicated to Clinical Research as a Care Option Launch by the Conference Forum

Share Article

The CRAACO: Clinical Research as a Care Option newsletter is the first publication solely dedicated to the work being done in uniting the worlds of clinical research and clinical care, for the benefit of patients and medicines development.

News Image
The conversations and actions connecting clinical research and clinical care are more important now than ever, which is why we are so pleased to announce the launch of a newsletter dedicated to highlighting voices making change in the space.

The Conference Forum is pleased to announce the launch of CRAACO: Clinical Research as a Care Option newsletter, the first publication solely dedicated to the work being done in uniting the worlds of clinical research and clinical care, for the benefit of patients and medicines development. The newsletter captures a wide range of perspectives on the challenges, opportunities, history and future of bridging the gap and breaking out of silos. The newsletter highlights voices from patient advocacy, healthcare systems, academia, pharmaceutical/biotechnology industry and clinical research organizations.

“The conversations and actions connecting clinical research and clinical care are more important now than ever, which is why we are so pleased to announce the launch of a newsletter dedicated to highlighting voices making change in the space,” said Andrew Goldstein, Producer of the corresponding Clinical Research as a Care Option conference.

The inaugural issue features the following topics: a patient’s experience in an NCI trial that saved her life; the history of separation between clinical care and clinical research; an integrated research organization’s work creating research infrastructures; emerging technology and processes in community hospital research; the role of clinical research as care in breast cancer treatment; a website aimed towards increasing the input of people of color in medicine development; and a university program creating the next generation of clinical research leaders.

"We’ve been reporting on CRAACO and the advances in integrating clinical care and clinical research through our annual conference and podcasts. So, it makes perfect sense to launch a dedicated newsletter to provide more support for the people leading this movement," said Valerie Bowling, Executive Director, the Conference Forum.

The following interviews are featured in the inaugural issue: Jamie Troil Goldfarb, patient advocate, clinical trial participant and cancer survivor; Amy Nordo, Global Product Development Strategic Partnerships, Pfizer; Jennifer Byrne, CEO, Javara; Mark J King, VP, Research & Innovation, Novant Health; Laura Esserman, MD, Director, Carol Franc Buck Breast Care Center, UCSF; Melanie Igwe, COO, Drugviu; Todd Johnson, VP, Wake Forest University, and Ralph D’Agostino, Jr, MD, Clinical Research Management program director.

The Conference Forum also presents the CRAACO: Clinical Research as a Care Option conference and CRAACO-related podcasts. With the conferences, podcasts and quarterly newsletters, the company provides helpful insights and ongoing support for the Clinical Research as a Care Option community.

About the Conference Forum:
The Conference Forum is a research firm and develops specialized content for professionals in the life science and healthcare industries. The company currently offers conferences and newsletters for R&D leaders, clinical development professionals, biotech executives, VCs, drug delivery specialists, patient advocates and non-profit/government healthcare groups. The Conference Forum's mission is to create the best content, facilitate the exchange of ideas and provide quality networking to help move therapeutics to patients faster. Learn more about The Conference Forum at theconferenceforum.org.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Allyson Adams
@ConferenceForum
Follow >
Visit website